Skip to main content
Clinical Trials/DRKS00004227
DRKS00004227
Completed
未知

Propofol Sedation for Colonoscopy with a New Ultrathin or a Standard Endoscope: a Prospective Randomized Controlled Study

EVK Evangelisches Krankenhaus DüsseldorfMedizinische Klinik0 sites203 target enrollmentJuly 4, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Consumption of sedative drugs during colonoscopy
Sponsor
EVK Evangelisches Krankenhaus DüsseldorfMedizinische Klinik
Enrollment
203
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2012
End Date
January 27, 2012
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
EVK Evangelisches Krankenhaus DüsseldorfMedizinische Klinik

Eligibility Criteria

Inclusion Criteria

  • Willingness to accept sedation on demand; ASA 1 or 2, age \= 18 years; indication screening, anemia, history of polypectomy, suspected gastrointestinal bleeding, abdominal complaints, irregular bowel habits

Exclusion Criteria

  • Patiens without informed consent, who wish deep sedation from the beginning, who wish no sedation from the beginning, with a history of partial colectomy, with previously known colorectal carcinoma, with previously known inflammatory bowel disease, with pregnancy or breastfeeding, with scheduled polypectomy, ASA 3 or 4

Outcomes

Primary Outcomes

Not specified

Similar Trials